Jussi Hirvonen

Prof. Dr. Jussi Hirvonen

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2007 in International Journal of Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
JHJussi Hirvonen
Jussi Hirvonen
HKHasse Karlsson
Hasse Karlsson
JKJaana Kajander
Jaana Kajander
ALAntti Lepola
Antti Lepola
JMJuha Markkula
Juha Markkula
JHJarmo Hietala
Jarmo Hietala
Serotonin (5-HT) is involved in the pathophysiology of major depressive disorder (MDD). Among the numerous serotonergic receptors, the 5-HT1A receptor

1 August 2020 in NeuroImage
Verified
Journal Article
Open access
TKTatu Kantonen
Tatu Kantonen
TKTomi Karjalainen
Tomi Karjalainen
JIJanne Isojärvi
Janne Isojärvi
PNPirjo Nuutila
Pirjo Nuutila
JTJouni Tuisku
Jouni Tuisku
LNLauri Nummenmaa
Lauri Nummenmaa
Alterations in the brain's μ-opioid receptor (MOR) system have been associated with several neuropsychiatric disorders. Central MOR availability also varies considerably in healthy individuals. Multiple epidemiological factors have been proposed to influence the MOR system, but due to small sample sizes the magnitude of their influence remains inconclusive. We compiled [11C]carfentanil positron emission tomography scans from 204 individuals with no neurologic or psychiatric disorders, and estimated the effects of sex, age, body mass index (BMI) and smoking on [11C]carfentanil binding potential using between-subject regression analysis. We also examined hemispheric differences in MOR availability. Older age was associated with increase in MOR availability in frontotemporal areas but decrease in amygdala, thalamus, and nucleus accumbens. The age-dependent increase was stronger in males. MOR availability was globally lowered in smokers but independent of BMI. Finally, MOR availability was higher in the right versus the left hemisphere. The presently observed variation in MOR availability may explain why some individuals are prone to develop MOR-linked pathological states, such as chronic pain or psychiatric disorders. Lateralized MOR system may reflect hemispheric work specialization in central emotion and pain processes.

19 July 2017 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
TSTiina Saanijoki
Tiina Saanijoki
LTLauri Tuominen
Lauri Tuominen
JTJetro J Tuulari
Jetro J Tuulari
LNLauri Nummenmaa
Lauri Nummenmaa
EAEveliina Arponen
Eveliina Arponen
JHJussi Hirvonen
Jussi Hirvonen
Central opioidergic mechanisms may modulate the positive effects of physical exercise such as mood elevation and stress reduction. How exercise intensity and concomitant effective changes affect central opioidergic responses is unknown. We studied the effects of acute physical exercise on the cerebral μ-opioid receptors (MOR) of 22 healthy recreationally active males using positron emission tomography (PET) and the MOR-selective radioligand [11C]carfentanil. MOR binding was measured in three conditions on separate days: after a 60-min aerobic moderate-intensity exercise session, after a high-intensity interval training (HIIT) session, and after rest. Mood was measured repeatedly throughout the experiment. HIIT significantly decreased MOR binding selectively in the frontolimbic regions involved in pain, reward, and emotional processing (thalamus, insula, orbitofrontal cortex, hippocampus, and anterior cingulate cortex). Decreased binding correlated with increased negative emotionality. Moderate-intensity exercise did not change MOR binding, although increased euphoria correlated with decreased receptor binding. These observations, consistent with endogenous opioid release, highlight the role of the μ-opioid system in mediating affective responses to high-intensity training as opposed to recreational moderate physical exercise.

21 January 2011 in Diabetes
Verified
Journal Article
Open access
PDF file
JHJussi Hirvonen
Jussi Hirvonen
KVKirsi A. Virtanen
Kirsi A. Virtanen
LNLauri Nummenmaa
Lauri Nummenmaa
JHJarna C. Hannukainen
Jarna C. Hannukainen
Miikka-Juhani HonkaMiikka-Juhani Honka
Miikka-Juhani Honka
PNPirjo Nuutila
Pirjo Nuutila
OBJECTIVE Insulin stimulates brain glucose metabolism, but this effect of insulin is already maximal at fasting concentrations in healthy subjects. It is not known whether insulin is able to stimulate glucose metabolism above fasting concentrations in patients with impaired glucose tolerance. RESEARCH DESIGN AND METHODS We studied the effects of insulin on brain glucose metabolism and cerebral blood flow in 13 patients with impaired glucose tolerance and nine healthy subjects using positron emission tomography (PET). All subjects underwent PET with both [18F]fluorodeoxyglucose (for brain glucose metabolism) and [15O]H2O (for cerebral blood flow) in two separate conditions (in the fasting state and during a euglycemic-hyperinsulinemic clamp). Arterial blood samples were acquired during the PET scans to allow fully quantitative modeling. RESULTS The hyperinsulinemic clamp increased brain glucose metabolism only in patients with impaired glucose tolerance (whole brain: +18%, P = 0.001) but not in healthy subjects (whole brain: +3.9%, P = 0.373). The hyperinsulinemic clamp did not alter cerebral blood flow in either group. CONCLUSIONS We found that insulin stimulates brain glucose metabolism at physiological postprandial levels in patients with impaired glucose tolerance but not in healthy subjects. These results suggest that insulin stimulation of brain glucose metabolism is maximal at fasting concentrations in healthy subjects but not in patients with impaired glucose tolerance.

14 March 2022 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
HHHeidi Huhtanen
Heidi Huhtanen
MNMikko Nyman
Mikko Nyman
TMTarek Mohsen
Tarek Mohsen
AVArho Virkki
Arho Virkki
AKAntti Karlsson
Antti Karlsson
JHJussi Hirvonen
Jussi Hirvonen
Background: The aim of this study was to develop and evaluate a deep neural network model in the automated detection of pulmonary embolism (PE) from computed tomography pulmonary angiograms (CTPAs) using only weakly labelled training data.Methods: We developed a deep neural network model consisting of two parts: a convolutional neural network architecture called InceptionResNet V2 and a long-short term memory network to process whole CTPA stacks as sequences of slices. Two versions of the model were created using either chest X-rays (Model A) or natural images (Model B) as pre-training data. We retrospectively collected 600 CTPAs to use in training and validation and 200 CTPAs to use in testing. CTPAs were annotated only with binary labels on both stack- and slice-based levels. Performance of the models was evaluated with ROC and precision–recall curves, specificity, sensitivity, accuracy, as well as positive and negative predictive values.Results: Both models performed well on both stack- and slice-based levels. On the stack-based level, Model A reached specificity and sensitivity of 93.5% and 86.6%, respectively, outperforming Model B slightly (specificity 90.7% and sensitivity 83.5%). However, the difference between their ROC AUC scores was not statistically significant (0.94 vs 0.91,p = 0.07).Conclusions: We show that a deep learning model trained with a relatively small, weakly annotated dataset can achieve excellent performance results in detecting PE from CTPAs.

1 February 2012 in NeuroImage
Verified
Journal Article
Closed access
SSSaurav Shrestha
Saurav Shrestha
JHJussi Hirvonen
Jussi Hirvonen
CHChristina S. Hines
Christina S. Hines
IHIoline D. Henter
Ioline D. Henter
Per SvenningssonPer Svenningsson
Per Svenningsson
RIRobert B. Innis
Robert B. Innis